97/100B235.255
USD
-4.06
(-1.69%)
Market Closed
Last updated: · Delayed 15 min
Fair value294.55Plus-20%185Price 235.26478
Q2 FY2027 · Earnings report
EPS estimate 3.03Revenue estimate 1.46B
Q2 FY2027 · Earnings report
EPS estimate 3.03Revenue estimate 1.46B
ResMed price to sales (P/S) ratio
ResMed's P/S ratio is 5.77: its market cap of 33.09B USD over revenue of 5.73B USD in the last twelve months.
- Today
- 5.77
- Average, 5 years
- 7.50
- Low, 5 years
- 4.53
- High, 5 years
- 11.29
P/S ratio = market cap ÷ revenue (last 12 months) = 33.09B ÷ 5.73B = 5.77
Each day's market cap over the revenue of the last four quarters reported by that day.
P/S ratio by year and by quarter
| Fiscal year | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Today | 5.77 | 33.09B | 5.73B | |
| FY2026 | 30 Jun 2026 | 4.99 | 28.20B | 5.65B |
| FY2025 | 30 Jun 2025 | 7.36 | 37.85B | 5.15B |
| FY2024 | 30 Jun 2024 | 5.87 | 27.48B | 4.69B |
| FY2023 | 30 Jun 2023 | 7.59 | 32.07B | 4.22B |
| FY2022 | 30 Jun 2022 | 8.56 | 30.62B | 3.58B |
| FY2021 | 30 Jun 2021 | 11.21 | 35.82B | 3.20B |
| FY2020 | 30 Jun 2020 | 9.37 | 27.71B | 2.96B |
| FY2019 | 30 Jun 2019 | 6.79 | 17.71B | 2.61B |
| FY2018 | 30 Jun 2018 | 6.32 | 14.79B | 2.34B |
| FY2017 | 30 Jun 2017 | 5.33 | 11.01B | 2.07B |
| FY2016 | 30 Jun 2016 | 4.82 | 8.87B | 1.84B |
| FY2015 | 30 Jun 2015 | 4.72 | 7.92B | 1.68B |
| FY2014 | 30 Jun 2014 | 4.61 | 7.16B | 1.55B |
| FY2013 | 30 Jun 2013 | 4.22 | 6.39B | 1.51B |
| FY2012 | 30 Jun 2012 | 3.33 | 4.55B | 1.37B |
| FY2011 | 30 Jun 2011 | 3.80 | 4.72B | 1.24B |
| FY2010 | 30 Jun 2010 | 4.20 | 4.59B | 1.09B |
| FY2009 | 30 Jun 2009 | 3.34 | 3.08B | 920.74M |
| FY2008 | 30 Jun 2008 | 3.31 | 2.77B | 835.40M |
| FY2007 | 30 Jun 2007 | 4.42 | 3.17B | 716.33M |
| FY2006 | 30 Jun 2006 | 5.59 | 3.40B | 607.00M |
| FY2005 | 30 Jun 2005 | 5.32 | 2.27B | 425.51M |
| FY2004 | 30 Jun 2004 | 5.06 | 1.72B | 339.34M |
| FY2003 | 30 Jun 2003 | 4.74 | 1.30B | 273.57M |
| FY2002 | 30 Jun 2002 | 4.39 | 895.72M | 204.08M |
| FY2001 | 30 Jun 2001 | 10.14 | 1.57B | 155.16M |
| FY2000 | 30 Jun 2000 | 6.98 | 806.89M | 115.62M |
| FY1999 | 30 Jun 1999 | 5.51 | 488.31M | 88.60M |
| FY1998 | 30 Jun 1998 | 4.98 | 331.07M | 66.50M |
| FY1997 | 30 Jun 1997 | 3.62 | 177.94M | 49.20M |
| FY1996 | 30 Jun 1996 | 3.32 | 114.75M | 34.60M |
| FY1995 | 30 Jun 1995 | 2.23 | 52.50M | 23.50M |
| FY1994 | 30 Jun 1994 | 2.58 | 35.83M | 13.90M |
| FY1993 | 30 Jun 1993 | 4.19 | 32.25M | 7.70M |
| Quarter | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Q1 FY2027 | 30 Sept 2026 | 5.51 | 31.61B | 5.73B |
| Q4 FY2026 | 30 Jun 2026 | 4.99 | 28.20B | 5.65B |
| Q3 FY2026 | 31 Mar 2026 | 5.94 | 32.88B | 5.54B |
| Q2 FY2026 | 31 Dec 2025 | 6.54 | 35.28B | 5.40B |
| Q1 FY2026 | 30 Sept 2025 | 7.63 | 40.09B | 5.26B |
| Q4 FY2025 | 30 Jun 2025 | 7.34 | 37.79B | 5.15B |
| Q3 FY2025 | 31 Mar 2025 | 6.54 | 32.84B | 5.02B |
| Q2 FY2025 | 31 Dec 2024 | 6.82 | 33.59B | 4.93B |
| Q1 FY2025 | 30 Sept 2024 | 7.46 | 35.85B | 4.81B |
| Q4 FY2024 | 30 Jun 2024 | 5.86 | 27.46B | 4.69B |
| Q3 FY2024 | 31 Mar 2024 | 6.07 | 27.82B | 4.58B |
| Q2 FY2024 | 31 Dec 2023 | 5.62 | 25.31B | 4.50B |
| Q1 FY2024 | 30 Sept 2023 | 4.97 | 21.75B | 4.38B |
| Q4 FY2023 | 30 Jun 2023 | 7.61 | 32.12B | 4.22B |
| Q3 FY2023 | 31 Mar 2023 | 8.01 | 32.17B | 4.02B |
| Q2 FY2023 | 31 Dec 2022 | 8.11 | 30.53B | 3.76B |
| Q1 FY2023 | 30 Sept 2022 | 8.82 | 31.97B | 3.62B |
| Q4 FY2022 | 30 Jun 2022 | 8.57 | 30.68B | 3.58B |
| Q3 FY2022 | 31 Mar 2022 | 10.02 | 35.46B | 3.54B |
| Q2 FY2022 | 31 Dec 2021 | 11.04 | 38.03B | 3.44B |
| Q1 FY2022 | 30 Sept 2021 | 11.46 | 38.39B | 3.35B |
| Q4 FY2021 | 30 Jun 2021 | 11.23 | 35.89B | 3.20B |
| Q3 FY2021 | 31 Mar 2021 | 9.12 | 28.20B | 3.09B |
| Q2 FY2021 | 31 Dec 2020 | 9.99 | 30.87B | 3.09B |
| Q1 FY2021 | 30 Sept 2020 | 8.20 | 24.84B | 3.03B |
| Q4 FY2020 | 30 Jun 2020 | 9.40 | 27.80B | 2.96B |
| Q3 FY2020 | 31 Mar 2020 | 7.37 | 21.30B | 2.89B |
| Q2 FY2020 | 31 Dec 2019 | 8.03 | 22.35B | 2.78B |
| Q1 FY2020 | 30 Sept 2019 | 7.19 | 19.42B | 2.70B |
| Q4 FY2019 | 30 Jun 2019 | 6.81 | 17.75B | 2.61B |
| Q3 FY2019 | 31 Mar 2019 | 5.94 | 15.00B | 2.53B |
| Q2 FY2019 | 31 Dec 2018 | 6.63 | 16.27B | 2.45B |
| Q1 FY2019 | 30 Sept 2018 | 6.83 | 16.43B | 2.40B |
| Q4 FY2018 | 30 Jun 2018 | 6.32 | 14.79B | 2.34B |
| Q3 FY2018 | 31 Mar 2018 | 6.19 | 14.07B | 2.27B |
| Q2 FY2018 | 31 Dec 2017 | 5.50 | 12.09B | 2.20B |
| Q1 FY2018 | 30 Sept 2017 | 5.15 | 10.95B | 2.12B |
| Q4 FY2017 | 30 Jun 2017 | 5.35 | 11.06B | 2.07B |
| Q3 FY2017 | 31 Mar 2017 | 5.03 | 10.20B | 2.03B |
| Q2 FY2017 | 31 Dec 2016 | 4.45 | 8.77B | 1.97B |
| Q1 FY2017 | 30 Sept 2016 | 4.82 | 9.12B | 1.89B |
| Q4 FY2016 | 30 Jun 2016 | 4.83 | 8.89B | 1.84B |
| Q3 FY2016 | 31 Mar 2016 | 4.57 | 8.11B | 1.77B |
| Q2 FY2016 | 31 Dec 2015 | 4.31 | 7.51B | 1.74B |
| Q1 FY2016 | 30 Sept 2015 | 4.18 | 7.15B | 1.71B |
| Q4 FY2015 | 30 Jun 2015 | 4.73 | 7.94B | 1.68B |
| Q3 FY2015 | 31 Mar 2015 | 6.16 | 10.11B | 1.64B |
| Q2 FY2015 | 31 Dec 2014 | 4.86 | 7.85B | 1.62B |
| Q1 FY2015 | 30 Sept 2014 | 4.38 | 6.90B | 1.58B |
| Q4 FY2014 | 30 Jun 2014 | 4.58 | 7.12B | 1.55B |
| Q3 FY2014 | 31 Mar 2014 | 4.05 | 6.30B | 1.55B |
| Q2 FY2014 | 31 Dec 2013 | 4.35 | 6.69B | 1.54B |
| Q1 FY2014 | 30 Sept 2013 | 4.89 | 7.50B | 1.53B |
| Q4 FY2013 | 30 Jun 2013 | 4.21 | 6.38B | 1.51B |
| Q3 FY2013 | 31 Mar 2013 | 4.51 | 6.64B | 1.47B |
| Q2 FY2013 | 31 Dec 2012 | 4.14 | 5.95B | 1.44B |
| Q1 FY2013 | 30 Sept 2012 | 4.13 | 5.76B | 1.39B |
| Q4 FY2012 | 30 Jun 2012 | 3.26 | 4.45B | 1.37B |
| Q3 FY2012 | 31 Mar 2012 | 3.33 | 4.45B | 1.34B |
| Q2 FY2012 | 31 Dec 2011 | 2.85 | 3.72B | 1.30B |
| Q1 FY2012 | 30 Sept 2011 | 3.39 | 4.33B | 1.28B |
| Q4 FY2011 | 30 Jun 2011 | 3.80 | 4.72B | 1.24B |
| Q3 FY2011 | 31 Mar 2011 | 3.83 | 4.57B | 1.19B |
| Q2 FY2011 | 31 Dec 2010 | 4.56 | 5.28B | 1.16B |
| Q1 FY2011 | 30 Sept 2010 | 4.41 | 4.97B | 1.13B |
| Q4 FY2010 | 30 Jun 2010 | 4.22 | 4.61B | 1.09B |
| Q3 FY2010 | 31 Mar 2010 | 4.56 | 4.80B | 1.05B |
| Q2 FY2010 | 31 Dec 2009 | 3.92 | 3.93B | 1.00B |
| Q1 FY2010 | 30 Sept 2009 | 3.59 | 3.41B | 949.80M |
| Q4 FY2009 | 30 Jun 2009 | 3.33 | 3.07B | 920.74M |
| Q3 FY2009 | 31 Mar 2009 | 2.96 | 2.68B | 903.93M |
| Q2 FY2009 | 31 Dec 2008 | 3.20 | 2.84B | 887.89M |
| Q1 FY2009 | 30 Sept 2008 | 3.75 | 3.25B | 867.59M |
| Q4 FY2008 | 30 Jun 2008 | 3.23 | 2.70B | 835.40M |
| Q3 FY2008 | 31 Mar 2008 | 4.13 | 3.27B | 791.56M |
| Q2 FY2008 | 31 Dec 2007 | 5.33 | 4.07B | 762.72M |
| Q1 FY2008 | 30 Sept 2007 | 4.50 | 3.32B | 738.47M |
| Q4 FY2007 | 30 Jun 2007 | 4.47 | 3.20B | 716.33M |
| Q3 FY2007 | 31 Mar 2007 | 5.57 | 3.88B | 696.20M |
| Q2 FY2007 | 31 Dec 2006 | 5.56 | 3.76B | 675.49M |
| Q1 FY2007 | 30 Sept 2006 | 4.75 | 3.06B | 643.47M |
| Q4 FY2006 | 30 Jun 2006 | 5.84 | 3.55B | 607.00M |
| Q3 FY2006 | 31 Mar 2006 | 5.69 | 3.19B | 561.25M |
| Q2 FY2006 | 31 Dec 2005 | 5.36 | 2.72B | 507.42M |
| Q1 FY2006 | 30 Sept 2005 | 6.03 | 2.80B | 464.90M |
| Q4 FY2005 | 30 Jun 2005 | 5.41 | 2.30B | 425.51M |
| Q3 FY2005 | 31 Mar 2005 | 4.95 | 1.94B | 392.97M |
| Q2 FY2005 | 31 Dec 2004 | 4.63 | 1.74B | 375.79M |
| Q1 FY2005 | 30 Sept 2004 | 4.55 | 1.61B | 354.19M |
| Q4 FY2004 | 30 Jun 2004 | 5.08 | 1.72B | 339.34M |
| Q3 FY2004 | 31 Mar 2004 | 4.65 | 1.52B | 327.14M |
| Q2 FY2004 | 31 Dec 2003 | 4.58 | 1.40B | 304.86M |
| Q1 FY2004 | 30 Sept 2003 | 5.14 | 1.48B | 287.86M |
| Q4 FY2003 | 30 Jun 2003 | 4.77 | 1.30B | 273.57M |
| Q3 FY2003 | 31 Mar 2003 | 4.25 | 1.06B | 249.12M |
| Q2 FY2003 | 31 Dec 2002 | 4.33 | 1.01B | 232.90M |
| Q1 FY2003 | 30 Sept 2002 | 4.34 | 940.43M | 216.53M |
| Q4 FY2002 | 30 Jun 2002 | 4.46 | 910.92M | 204.08M |
| Q3 FY2002 | 31 Mar 2002 | 6.60 | 1.29B | 194.86M |
| Q2 FY2002 | 31 Dec 2001 | 9.35 | 1.73B | 184.76M |
| Q1 FY2002 | 30 Sept 2001 | 9.59 | 1.63B | 170.20M |
| Q4 FY2001 | 30 Jun 2001 | 10.24 | 1.59B | 155.16M |
| Q3 FY2001 | 31 Mar 2001 | 9.04 | 1.26B | 139.69M |
| Q2 FY2001 | 31 Dec 2000 | 9.75 | 1.24B | 126.98M |
| Q1 FY2001 | 30 Sept 2000 | 7.97 | 962.50M | 120.72M |
| Q4 FY2000 | 30 Jun 2000 | 6.91 | 798.73M | 115.54M |
| Q3 FY2000 | 31 Mar 2000 | 10.05 | 1.10B | 109.07M |
| Q2 FY2000 | 31 Dec 1999 | 6.15 | 626.40M | 101.90M |
| Q1 FY2000 | 30 Sept 1999 | 5.16 | 491.67M | 95.30M |
| Q4 FY1999 | 30 Jun 1999 | 5.47 | 484.76M | 88.60M |
| Q3 FY1999 | 31 Mar 1999 | 5.00 | 414.19M | 82.80M |
| Q2 FY1999 | 31 Dec 1998 | 8.19 | 631.80M | 77.10M |
| Q1 FY1999 | 30 Sept 1998 | 5.27 | 378.18M | 71.70M |
| Q4 FY1998 | 30 Jun 1998 | 4.99 | 331.64M | 66.50M |
| Q3 FY1998 | 31 Mar 1998 | 4.09 | 250.25M | 61.20M |
| Q2 FY1998 | 31 Dec 1997 | 3.58 | 202.40M | 56.60M |
| Q1 FY1998 | 30 Sept 1997 | 3.44 | 179.30M | 52.10M |
| Q4 FY1997 | 30 Jun 1997 | 3.40 | 167.20M | 49.20M |
| Q3 FY1997 | 31 Mar 1997 | 2.58 | 118.34M | 45.80M |
| Q2 FY1997 | 31 Dec 1996 | 3.66 | 156.40M | 42.70M |
| Q1 FY1997 | 30 Sept 1996 | 3.24 | 126.51M | 39.00M |
| Q4 FY1996 | 30 Jun 1996 | 3.03 | 104.91M | 34.60M |
| Q3 FY1996 | 31 Mar 1996 | 2.74 | 84.00M | 30.70M |
| Q2 FY1996 | 31 Dec 1995 | 1.89 | 50.87M | 26.90M |
| Q1 FY1996 | 30 Sept 1995 | 2.82 | 69.49M | 24.60M |
| Q4 FY1995 | 30 Jun 1995 | 2.23 | 52.50M | 23.50M |
| Q3 FY1995 | 31 Mar 1995 | 2.33 | 47.03M | 20.20M |
| Q2 FY1995 | 31 Dec 1994 | 2.60 | 47.03M | 18.10M |
| Q1 FY1995 | 30 Sept 1994 | 2.94 | 47.03M | 16.00M |
| Q4 FY1994 | 30 Jun 1994 | 2.78 | 38.59M | 13.90M |
| Q3 FY1994 | 31 Mar 1994 | 3.23 | 40.31M | 12.50M |
| Q2 FY1994 | 31 Dec 1993 | 3.70 | 40.31M | 10.90M |
| Q1 FY1994 | 30 Sept 1993 | 4.33 | 40.31M | 9.30M |
| Q4 FY1993 | 30 Jun 1993 | 4.65 | 35.83M | 7.70M |
| Q3 FY1993 | 31 Mar 1993 | — | 35.83M | — |
| Q2 FY1993 | 31 Dec 1992 | — | 42.08M | — |
| Q1 FY1993 | 30 Sept 1992 | — | 42.08M | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about ResMed's P/S ratio
Source: Financial Modeling Prep